semaglutide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42624612
Cognitive signs and symptoms in people with a psychiatric diagnosis on semaglutide: a retrospective cohort study of 13 007 patients in the USA.
Cognitive signs and symptoms in people with a psychiatric diagnosis on semaglutide: a retrospective cohort study of 13 007 patients in the USA.
- 저자
- Riccardo De Giorgi, Nadia Lipunova, Elgan Mathias, Fei Shang, Maxime Taquet
- 저널
- BMJ mental health
- 공개일
- 2026 Aug 20
- 연구 유형
- 기타
- DOI
- 10.1136/bmjment-2026-302828
문헌 요약
Cognitive deficits across psychiatric disorders are common and difficult to treat. Semaglutide, a GLP-1 receptor agonist, shows potential cognitive benefits in diabetes and obesity, but effects in psychiatric populations remain unclear. To determine whether initiation of semaglutide is associated with fewer cognitive signs/symptoms over 12 months among ad…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.